Skip to main content

Table 6 Inter-relationships between the clinicopathological characteristics in patients with ER positive primary operable invasive ductal breast cancer (n = 237)

From: The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer

 

  Size

  Grade

Involved lymph node

PR status

HER-2 status

Ki-67 status

  LVI

  MVD

Loco-regional treatment

Systemic treatment

 

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

( P-value)

Age (≤50/>50 years)

0.058

0.236

0.495

0.297

0.054

0.641

0.913

0.238

0.261

<0.001

Size (≤20/21-50/>50 mm)

 

0.033

<0.001

0.879

0.826

0.041

<0.001

0.568

<0.001

0.438

Grade (I/II/III)

  

0.258

0.753

<0.001

<0.001

<0.001

0.072

0.108

0.627

Involved lymph node (0/1-3/>3)

   

0.157

0.323

0.035

<0.001

0.607

0.001

0.013

Progesterone –receptor status (PR-/PR+)

    

0.002

0.340

0.392

0.997

0.256

0.804

HER-2 status (HER-2 -/HER-2+)

     

0.020

0.119

0.627

0.363

0.603

Ki-67 proliferative activity (Low Ki-67/High Ki-67)

      

0.049

0.041

0.598

0.289

LVI (Absent/Present)

       

0.215

0.031

0.255

MVD (tertiles 1, 2, 3)

        

0.628

0.402

Loco-regional treatment (Lumpectomy + radiotherapy/mastectomy + radiotherapy)

         

0.057

  1. Bold data reflects an association between the two variables.